- Home
- ABVX vs DLY Comparison
ABVX vs DLY Comparison
Compare ABVX & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- DLY
- Stock Information
- Founded
- ABVX 2013
- DLY 2019
- Country
- ABVX France
- DLY United States
- Employees
- ABVX N/A
- DLY N/A
- Industry
- ABVX
- DLY Investment Managers
- Sector
- ABVX
- DLY Finance
- Exchange
- ABVX Nasdaq
- DLY Nasdaq
- Market Cap
- ABVX 722.3M
- DLY 787.5M
- IPO Year
- ABVX N/A
- DLY N/A
- Fundamental
- Price
- ABVX $9.50
- DLY $16.00
- Analyst Decision
- ABVX Strong Buy
- DLY
- Analyst Count
- ABVX 6
- DLY 0
- Target Price
- ABVX $36.50
- DLY N/A
- AVG Volume (30 Days)
- ABVX 82.3K
- DLY 215.9K
- Earning Date
- ABVX 09-09-2024
- DLY 01-01-0001
- Dividend Yield
- ABVX N/A
- DLY 8.93%
- EPS Growth
- ABVX N/A
- DLY N/A
- EPS
- ABVX N/A
- DLY N/A
- Revenue
- ABVX $9,676,417.00
- DLY N/A
- Revenue This Year
- ABVX $31.67
- DLY N/A
- Revenue Next Year
- ABVX $1,189.66
- DLY N/A
- P/E Ratio
- ABVX N/A
- DLY N/A
- Revenue Growth
- ABVX 100.87
- DLY N/A
- 52 Week Low
- ABVX $8.75
- DLY $13.26
- 52 Week High
- ABVX $17.02
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- ABVX 34.50
- DLY 43.88
- Support Level
- ABVX $10.27
- DLY $16.03
- Resistance Level
- ABVX $10.79
- DLY $16.54
- Average True Range (ATR)
- ABVX 0.36
- DLY 0.20
- MACD
- ABVX -0.05
- DLY 0.02
- Stochastic Oscillator
- ABVX 8.16
- DLY 44.95
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is organized as a non-diversified, limited-term, closed-end management investment company. The Fund's investment objective is to seek a high level of total return, with an emphasis on current income.